San Diego-based SpineMark, a network of spine centers, has appointed Alan Donald, M.S., M.B.A to the president of SpineMark CRO Management. The company also appointed Alan Iftiniuk as its interim chief operating officer. Donald has 25 years of experience working in drug, medical device and diagnostic companies. In 1999, Iftiniuk was president and chief executive officer of Good Shepherd Hospital in Barrington Ill., now a SpineMark Center. Prior to SpineMark, he worked at growing both commercial and non-profit hospital-based entities.
Cincinnati-based CRO Kendle promoted Ken Hintze, Ph.D, to the position of vice president of global clinical safety and pharmacovigilance. Recently, Hintze was senior director for the department. He joined Kendle in 2002 after a 23 year career at Proctor & Gamble where he held various roles involving product safety.
Pennsylvania-based CRO Omnicare Clinical Research promoted Nancy Meyerson-Hess to the role of senior vice president of international project management. Meyerson-Hess previously served as vice president of the group. Prior Omnicare Clinical Research, she held the position of director of project management for Central Europe at PRA International.
Philadelphia-based Premier Research Group named W. Scott Keenen to the position of vice president of global human resources. Just prior to Premier Research, Keenen was global director human resources for inCode Telecom. Premier also appointed Melissa Jones to the position of vice president of international business development. Jones previously held positions at Kendle, Quintiles, MDS Pharma Services and Innovex.
Dublin-based CRO ICON hired Dr. David Shaw to the newly created position of senior director of ICON Development Services’ EU Regulatory Affairs department. Prior to ICON, Shaw was the founder and director of PharmDev Consulting Services. He also held senior roles at Johnson & Johnson as director of global pre-clinical development and at Elan as director of development and regulatory affairs.
Massachusetts-based imaging CRO WorldCare Clinical hired Carol Adiletto to the position of senior vice president of clinical operations and regulatory affairs. Prior to WorldCare, she held positions at Pluromed and Inverness Medical Innovations.
Cellectar, a radiopharmaceuticals company, appointed Ernest Allen to director of clinical operations and
LisaAnn Trembath to manager of medical affairs. Prior to Cellectar, Allen held senior posts at UK-based CRO Origin Pharmaceuticals, Parke-Davis, Amgen and Alcon. Most recently he was clinical manager for
Tapestry Pharmaceuticals. Trembath has 21 years in the medical imaging, including 10 years in clinical research. Prior to Cellectar, Trembath was senior clinical affairs specialist in the medical affairs division of Bristol-Myers Squibb Medical imaging.
New York-based eClinical Company Medidata Solutions appointed key personnel to the company’s safety and quality assurance department. The appointments include Barton Cobert, M.D., to vice president of global regulatory initiatives and pharmacovigilance, Frances Nolan to vice president of global quality assurance and Tony Hewer, senior director of global quality assurance for EMEA. Colbert previously served as global head of drug safety and pharmacovigilance at Novartis’ consumer health division. Nolan held numerous positions in IT at Taratec Development, Pfizer and Oracle. Brewer worked in various senior IT positions at Pfizer, Braxxon Technology and Data Logic.